Clapés S, Fernández T, Suárez G

Language: English
References: 20
Page: 37-40
PDF size: 133.86 Kb.

ABSTRACT

Hyperglycemia characteristic of diabetes mellitus triggers pathological processes in fetal development of various structures such as the retina, peripheral nerves, renal glomerulus, and arterial and venous beds. Women with diabetes prior to conception have children with birth defects three to five times more frequently than women without diabetes. There is no specific pattern of birth defects, but the central nervous and cardiovascular systems are the most affected. Hyperglycemia leads to mitochrondrial superoxide radical production, which activates five metabolic pathways that mediate damage leading to diabetic embryopathy. Once oxidative stress is established, there is modification of gene expression controlling embryonic development in critical periods. Vitamin E application in animal models has greatly lowered occurrence of birth defects in embryonic and fetal stages, consistent with an etiologic role for oxidative stress in dysmorphogenesis. Effective metabolic control before and during pregnancy, achieved in Cuba by implementing programs for control of birth defects in children of diabetic pregnant women, has been found effective.

REFERENCES

1. Ashcroft FM, Rorsman P. Diabetes mellitus and the β Cell: the last ten years. Cell. 2012 Mar 16;148(6):1160–71.

2. Inzucchi SE. Clinical practice. Diagnosis of diabetes. N Engl J Med. 2012 Aug 9;367(6):542–50.

3. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010 Oct 29;107(9):1058–70.

4. Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstet Gynecol. 1996 Apr;174(4):1343–53.

5. Anuario Estadístico 2011 [Internet]. Havana: Ministry of Public Health (CU); 2012 [cited 2012 Jun 23]. Available from: http://fi les.sld.cu/dne/ fi les/2012/04/anuario-2011-e.pdf. Spanish.

6. Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes. 1980 Dec;29(12):1023–35.

7. Fetita LS, Sobngwi E, Serradas P, Calvo F, Gautier JF. Consequences of fetal exposure to maternal diabetes in offspring. J Clin Endocrinol Metab. 2006 Oct;91(10):3718–24.

8. Loeken MR. Advances in understanding the molecular causes of diabetes-induced birth defects. Soc Gynecol Investig. 2006 Jan;13(1):2–10.

9. Ericksson UJ, Cederberg J, Wentzel P. Congenital malformations in offspring of diabetic mothers. Animal and human studies. Rev Endocr Metab Disord. 2003 Mar;4(1):79–93.

10. González E. Diabetes experimental: etiología de malformaciones congénitas en descendientes de ratas diabéticas. Rev Cubana Endocrinol. 2002;13(1):53–63. Spanish.

11. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med. 2002 Apr;19(4):322–6.

12. Chen CP. Congenital malformations associated with maternal diabetes. Taiwanese J Obstet Gynecol. 2005 Mar 1;44(1):1–7.

13. Wu Y, Viana M, Thirumangalathu S, Loeken MR. AMP-activated protein kinase mediates effects of oxidative stress on embryo gene expression in a mouse model of diabetic embryopathy. Diabetologia. 2012 Jan;55(1):245–54.

14. Long YC, Zierath JR. AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest. 2006 Jul;116(7):1776–83.

15. Gorrita Y, Núñez N, Fernández T, Clapés S. Malformaciones congénitas en la descendencia de ratas diabéticas [Congenital anomalies in diabetic rats descendants]. Rev Haban Cienc Med. Spanish. Forthcoming.

16. Marcheco B. El programa nacional de diagnóstico, manejo y prevención de enfermedades genéticas y defectos congénitos de Cuba: 1981– 2009. Rev Cubana Genética Comun. 2009;3 (2-3):167–84. Spanish.

17. Guillén M, Valdés L, Lang J. Programa Nacional Cubano de Atención Integral a la Gestante con Diabetes Mellitus. Conferencia. Libro resumen COPAEN 2012. XIII Congreso Latinoamericano de Endocrinología; 2012 May 11; Havana, Cuba. p 11. Spanish.

18. Álvarez AG, García A, Gorbea MH. Pautas conceptuales y metodológicas para explicar los determinantes de los niveles de salud en Cuba. Rev Cubana Salud Pública. 2007;33(2). Spanish.

19. McElvy SS, Miodovnik M, Rosenn B, Khoury JC, Siddigi T, Dignan PS, et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J Matern Fetal Med. 2000 Jan–Feb;9(1):14–20.

20. Vigneri R, Squatrito S, Frittitta L. Selective insulin receptor modulators (SIRM): a new class of antidiabetes drugs? Diabetes. 2012 May;61(5):984–5.